Dexlansoprazol — supply status, manufacturers & alternatives

Dexlansoprazol

—

In supply · Australia

In supply · 🇦🇺 Australia · short in🌐 CO

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Dexlansoprazol
Therapeutic category	Auto-created by INVIMA — Desabastecimiento de medicamentos (Colombia) scraper
Controlled substance	No
Marketing-authorisation holders	Mylan Pharmaceuticals Inc., APOTEX INC, TAKEDA CANADA INC

Registrations on file	4

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders4 registrations · 3 MA holders

Product	Strength	Form	Market	MA holder	Status
Dexlansoprazole	30mg/1	capsule	🇺🇸 US	Mylan Pharmaceuticals Inc.	Active
Dexlansoprazole	60mg/1	capsule	🇺🇸 US	Mylan Pharmaceuticals Inc.	Active
Apo-Dexlansoprazole	—	capsule	🇨🇦 CA	APOTEX INC	Active
Dexlansoprazole	—	capsule	🇨🇦 CA	TAKEDA CANADA INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.